Share on Facebook Share on Twitter Share on LinkedIn Share on Google+ Share by Email

Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Programs
    Programs
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
  • Organisations
    Organisations
  • Health Services MapHealth Services Map
Australian Indigenous HealthBulletin Alcohol and other drugs knowledge centre Yarning Places
 

Publications

2017

Australian Indigenous HealthInfoNet (2017)

Summary of Aboriginal and Torres Strait Islander health status 2016.

Perth, WA: Australian Indigenous HealthInfoNet

Basnayake TL, Morgan LC, Chang AB (2017)

The global burden of respiratory infections in Indigenous children and adults: a review.

Respirology; Early view(https://doi.org/10.1111/resp.13131):

Collins DA, Hoskins A, Snelling T, Senasinghe K, Bowman J, Stemberger NA, Leach AJ, Lehmann D (2017)

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population.

Pneumonia; 9: 14

Retrieved 25 September 2017 from https://doi.org/10.1186/s41479-017-0038-x

The 2017 influenza guide for general practitioners (2017)

Influenza Specialist Group

This fact sheet provides general practitioners with guidelines for influenza vaccinations for 2017. Information is included on:

  • background information and statistics regarding the influenza and vaccination
  • who should receive the vaccination
    • older people
    • Aboriginal and Torres Strait Islander people
    • pregnant women
    • people with an existing medical condition complicated by influenza
  • timing of vaccination for elderly patients.

Australian Indigenous HealthInfoNet abstract

Moberley S, Licciardi PV, Balloch A, Andrews R, Leach AJ, Kirkwood M, Binks P, Mulholland K, Carapetis J, Tang MLK, Skull S (2017)

Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness.

Vaccine; In Press(https://doi.org/10.1016/j.vaccine.2017.04.040): 1-8

Pearce DC, McCaw JM, McVernon J, Mathews JD (2017)

Influenza as a trigger for cardiovascular disease: an investigation of serotype, subtype and geographic location.

Environmental Research; 156: 688-696

Pennington K, Enhanced Invasive Pneumococcal Disease Surveillance Working Group (2017)

Invasive pneumococcal disease surveillance, 1 October to 31 December 2016.

Communicable Diseases Intelligence; 41(1): E114-E119

2016

Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, Upham J, Kotsimbos T, Kelly P, Cheng AC (2016)

Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).

Eurosurveillance; 21(30)

Retrieved 28 July 2016 from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22527

Cheng AC, Holmes M, Dwyer DE, Irving LB, Korman TM, Senanayake S, Macartney KK, Blyth CC, Brown S, Waterer GW, Hewer R, Friedman ND, Wark PA, Simpson G, Upham JW, Bowler SD, Lessing A, Kotsimbos T, Kelly PM (2016)

Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network.

Communicable Diseases Intelligence; 40(4): E521-E526

Corvisy R, Hood J, Enhanced Invasive Pneumococcal Disease Surveillance Working Group (2016)

Invasive pneumococcal disease surveillance, 1 July to 30 September 2016.

Communicable Diseases Intelligence; 40(4): E569-E573

Dalton CB, Carlson SJ, Durrheim DN, Butler MT, Cheng AC, Kelly HA (2016)

Flutracking weekly online community survey of influenza-like illness annual report, 2015.

Communicable Diseases Intelligence; 40(4): E512-E520

de Kluyver R, Toms C (2016)

Invasive pneumococcal disease surveillance Australia, 1 October to 31 December 2015.

Communicable Diseases Intelligence; 40(1): E185-E188

Dey A, Knox S, Wang H, Beard FH, McIntyre PB (2016)

Summary of national surveillance data on vaccine preventable diseases in Australia, 2008-2011.

Communicable Diseases Intelligence; 40(Supplement): S1-S70

Dunne EM, Carville K, Riley TV, Bowman J, Leach AJ, Cripps AW, Murphy D, Jacoby P, Lehmann D (2016)

Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles.

Pneumonia; 8: 15

Retrieved 5 September 2016 from http://dx.doi.org/10.1186/s41479-016-0015-9

Dyda A, Karki S, Hayen A, MacIntyre CR, Menzies R, Banks E, Kaldor JM, Liu B (2016)

Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake.

BMC Infectious Diseases; 16: 515

Retrieved 26 September 2016 from http://dx.doi.org/10.1186/s12879-016-1820-8

Gibney KB, Cheng AC, Hall R, Leder K (2016)

An overview of the epidemiology of notifiable infectious diseases in Australia, 1991–2011.

Epidemiology and Infection; Firstview(http://dx.doi.org/10.1017/S0950268816001072):

Glynn-Robinson A, Pennington K, Toms C, Enhanced Invasive Pneumococcal Disease Surveillance Working Group (2016)

Invasive pneumococcal disease surveillance, 1 April to 30 June 2016.

Communicable Diseases Intelligence; 40(4): E564-E568

Antiviral treatments for influenza (2016)

Influenza Specialist Group

This guide has been prepared to assist medical practitioners in making treatment decisions for patients presenting with influenza-like illness, particularly those most vulnerable to severe disease, and for short-term prophylaxis (treatment given or action taken to prevent disease).

The guide answers the following questions:

  • Which antiviral treatments are available in Australia?
  • How do influenza antiviral drugs work?
  • when to use these drugs (tamiflu and relenza)
  • treatment with these drugs
  • current Australian licences for the use of the these drugs
  • side effects
  • effectiveness as a treatment
  • recommendations.

Australian Indigenous HealthInfoNet abstract

The 2016 pneumococcal disease guide for general practitioners (2016)

Influenza Specialist Group

This factsheet is a guide for general practitioners treating patients with pneumococcal disease. The factsheet describes:

  • pneumococcal disease
  • antibiotic resistance
  • transmission
  • clinical features
  • who is most at risk
  • adult vaccination recommendations.

Australian Indigenous HealthInfoNet abstract

Li-Kim-Moy J, Yin J, Patel C, Beard FH, Chiu C, Macartney KK, McIntyre PB (2016)

Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015.

Communicable Diseases Intelligence; 40(4): E482-E495

National Notifiable Diseases Surveillance System Annual Report Writing Group (2016)

Australia’s notifiable disease status, 2014: annual report of the National Notifiable Diseases Surveillance System.

Canberra: National Notifiable Diseases Surveillance System

Pennington K, Glynn-Robinson A, Toms C (2016)

Invasive pneumococcal disease surveillance, 1 January to 31 March 2016.

Communicable Diseases Intelligence; 40(2): E308-E312

Toms C, de Kluyver R (2016)

Invasive pneumococcal disease in Australia, 2011 and 2012.

Communicable Diseases Intelligence; 40(2): E267-E284

2015

Bareja C, Toms C, Lodo K, de Kluyver R (2015)

Invasive pneumococcal disease in Australia, 2009 and 2010.

Communicable Diseases Intelligence; 39(2): E265-E279

Burns J, Burrow S, Drew N, Elwell M, Gray C, Harford-Mills M, Hoareau J, Lynch R, MacRae A, O’Hara T, Potter C, Ride K, Trzesinski A (2015)

Overview of Australian Indigenous health status, 2014.

Perth, WA: Australian Indigenous HealthInfoNet

This report provides recent information on:

  • Aboriginal and Torres Strait Islander populations
  • the context of Indigenous health
  • various measures of population health status
  • selected health conditions
  • health risk and protective factors.

This Overview draws on statistics and other published and unpublished materials to provide up-to-date, detailed information about the health of Aboriginal and Torres Strait Islander peoples in 2014. It highlights a number of improvements in certain aspects of Indigenous health, but underlines that ongoing work is needed to 'close the gap' in health status between Indigenous and other Australians.

Australian Indigenous HealthInfoNet abstract

Burns J, Burrow S, Drew N, Elwell M, Gray C, Harford-Mills M, Hoareau J, Lynch R, MacRae A, O’Hara T, Potter C, Ride K, Trzesinski A (2015)

Summary of Australian Indigenous health status, 2014.

Perth: Australian Indigenous HealthInfoNet

Chidgzey PJ, Davis S, Williams P, Reeve C (2015)

An outbreak of influenza A (H1N1) virus in a remote Aboriginal community post-pandemic: implications for pandemic planning and health service policy.

Australian and New Zealand Journal of Public Health; 39(1): 15–20

de Kluyver R, Toms C (2015)

Invasive pneumococcal disease surveillance Australia, 1 July to 30 September 2015.

Communicable Diseases Intelligence; 39(4): E639-E643

de Kluyver R (2015)

Invasive pneumococcal disease surveillance Australia, 1 April to 30 June 2015.

Communicable Diseases Intelligence; 39(3): E499-E502

de Kluyver R (2015)

Invasive pneumococcal disease surveillance Australia, 1 January to 31 March 2015.

Canberra: National Notifiable Diseases Surveillance System

de Kluyver R (2015)

Invasive pneumococcal disease surveillance Australia, 1 July to 30 September 2014.

Canberra: National Notifiable Diseases Surveillance System

de Kluyver R (2015)

Invasive pneumococcal disease surveillance Australia, 1 October to 31 December 2014.

Canberra: National Notifiable Diseases Surveillance System

Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, Krause V, McIntyre P (2015)

Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

Vaccine; In press(http://dx.doi.org/10.1016/j.vaccine.2015.10.089):

National Notifiable Diseases Surveillance System Annual Report Writing Group (2015)

Australia’s notifiable disease status, 2012: annual report of the National Notifiable Diseases Surveillance System.

Canberra: National Notifiable Diseases Surveillance System

National Notifiable Diseases Surveillance System Annual Report Writing Group (2015)

Australia’s notifiable disease status, 2013: annual report of the National Notifiable Diseases Surveillance System.

Canberra: National Notifiable Diseases Surveillance System

2014

Brown J, Simpson G (2014)

Diffuse panbronchiolitis in an Australian Aborigine.

Respiratory Case Reports; 2(2): 64–66

Chen Y, Williams E, Kirk M (2014)

Risk factors for acute respiratory infection in the Australian community.

PLOS ONE; 9(7): e101440

Retrieved 17 July 2014 from http://dx.doi.org/10.1371/journal.pone.0101440

Cheng AC, Dwyer DE, Holmes M, Irving LB, Brown SGA, Waterer GW, Korman TM, Hunter C, Hewagama S, Friedman ND, Wark PA, Simpson G, Upham JW, Bowler SD, Senenayake SN, Kotsimbos TC, Kelly PM (2014)

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network.

Communicable Diseases Intelligence; 38(2): E143-E149

de Kluyver R (2014)

Invasive pneumococcal disease surveillance Australia, 1 April to 30 June 2014.

Communicable Diseases Intelligence; 28(3): E266-E270

de Kluyver R (2014)

Invasive pneumococcal disease surveillance Australia, 1 January to 31 March 2014.

Communicable Diseases Intelligence; 38(2): E169-E173

de Kluyver R (2014)

Invasive pneumococcal disease surveillance Australia, 1 October to 31 December 2013.

Communicable Diseases Intelligence; 38(1): E88-E92

Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB (2014)

Immunisation coverage, 2012.

Communicable Diseases Intelligence; 38(3): E208-E231

Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB (2014)

Immunisation coverage annual report, 2011.

Communicable Diseases Intelligence; 37(4): E291-E312

Lim FJ, Lehmann D, McLoughlin A, Harrison C, Willis J, Giele C, Keil AD, Moore HC (2014)

Risk factors and comorbidities for invasive pneumococcal disease in Western Australian Aboriginal and non-Aboriginal people.

Pneumonia; 4(2014): 24-34

Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG (2014)

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Pediatric Infectious Disease Journal; 33(1,S2): S107-S187

Queensland Health (2014)

Queensland Health pandemic influenza plan.

Brisbane: Queensland Health

The Queensland Health pandemic influenza plan provides a strategic outline of Queensland Health responses to an influenza pandemic. Links to resources including guidelines and tools to assist hospital and health services with operational planning are detailed throughout the plan and also listed in appendix three.

Abstract adapted from Queensland Health

Quiñones-Parra S, Grant E, Loh L, Nguyen THO, Campbell K, Tong SYC, Miller A, Doherty PC, Vijaykrishna D, Rossjohn J, Gras S, Kedzierska K (2014)

Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.

Proceedings of the National Academy of Sciences; 111(3): 1049–1054

Singleton RJ, Valery PC, Morris P, Byrnes CA, Grimwood K, Redding G, Torzillo PJ, McCallum G, Chikoyak L, Mobberly C, Holman RC, Chang AB (2014)

Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Pediatric Pulmonology; 49(2): 189–200

Steering Committee for the Review of Government Service Provision (2014)

Overcoming Indigenous disadvantage: key indicators 2014.

Canberra: Productivity Commission

This report measures the wellbeing of Aboriginal and Torres Strait Islander Australians. It is the sixth report in a series commissioned by all Australian governments, designed to measure progress in overcoming the disadvantage faced by many Aboriginal and Torres Strait Islander Australians. Aboriginal and Torres Strait Islander Australians have been actively involved in the development and production of the report. The report measures the progress of the six targets set by the Council of Australian Governments Closing the gap strategy, together with other identified significant indicators. The report has three main sections:

  • an overview of the key messages
  • the main report which provides the evidence base for the framework for the report and detailed information on outcomes
  • tables expanding on the data presented in the report.

The information in this report can help inform the design of policies.

Abstract adapted from Productivity Commission

Xu Z, Liu Y, Ma Z, Li S, Hu W, Tong S (2014)

Impact of temperature on childhood pneumonia estimated from satellite remote sensing.

Environmental Research; 132(http://dx.doi.org/10.1016/j.envres.2014.04.021): 334-341

2013

Abbott P, Menzies R, Davison J, Moore L, Wang H (2013)

Improving immunisation timeliness in Aboriginal children through personalised calendars.

BMC Public Health; 13: 598

Retrieved 20 June 2013 from http://dx.doi.org/10.1186/1471-2458-13-598

Australian Department of Health Immunise Australian Program (2013)

National immunisation strategy for Australia 2013-2018.

Canberra: Australia Department of Health

Australian Institute of Health and Welfare (2013)

Healthy for life: results for July 2007-June 2011.

Canberra: Australian Institute of Health and Welfare

This report presents data from services receiving Healthy for life (HfL) funding, including the number of clients and health outcomes measured by 10 essential indicators (EIs) covering maternal and child health and chronic disease care:

  • timing of first antenatal visit
  • average birthweight
  • low and high birthweight babies
  • risk factors identified during pregnancy
  • immunisation rates
  • conduct of adult health checks
  • chronic disease management plans, GP management plans and team care arrangements
  • glycosylated haemoglobin (HbA1c) blood tests for clients with type 2 diabetes (whether done in the last 6 months, and the results)
  • blood pressure tests for clients with type 2 diabetes (whether done in the last 6 months, and the results)
  • blood pressure tests for clients with coronary heart disease (whether done in the last 6 months, and the results)

It is the first publicly released report published since data collection and reporting for the Healthy for life program began in 2007. Healthy for life (HfL) program was established with a set of key objectives to improve the health of Aboriginal and Torres Strait Islander people. The report provides comparisons over time, making it easy to see how the program has developed and its major achievements.

About 100 health services were funded as part of the program, but not all were required to provide data. Those providing data for the report represent 85% of all services funded in the 2010-11 reporting period. The services are widely distributed in every state and territory, from major cities to very remote areas.

The HfL aligns with the principles and priorities of the National Strategic Framework for Aboriginal and Torres Strait Islander Health (NSF), 2003- 2013 and the Council of Australian Governments (COAG) Closing the gap initiative, and is the first Office for Aboriginal and Torres Strait Islander Health (OATSIH) funded program with a strong focus on continuous quality improvement (CQI) to collect and report on health outcome data that goes beyond service activity reporting.

Abstract adapted from the Australian Institute of Health and Welfare (AIHW)

Bar-Zeev N (2013)

The contribution of influenza and other respiratory viruses to the burden of pneumonia among Indigenous children in the Top End of the Northern Territory.

Doctor of Philosophy thesis, Charles Darwin University: Darwin

Bareja C, Enhanced Invasive Pneumococcal Disease Surveillance Working Group (2013)

Enhanced Invasive Pneumococcal Disease Surveillance Working Group – quarterly surveillance report.

Communicable Diseases Intelligence; 37(2): E175-E178

Bareja C (2013)

Invasive pneumococcal disease surveillance Australia, 1 April to 30 June 2013.

Communicable Diseases Intelligence; 37(3): E286-E290

Chen Y, Kirk MD (2013)

Incidence of acute respiratory infections in Australia.

Epidemiology and Infection; 142(7): 1355-1361

Cheng AC, Brown SG, Waterer GW, Holmes M, Senenayake S, Friedman ND, Hewagama S, Simpson G, Wark PA, Upham JW, Korman TM, Dwyer DE, Wood-Baker R, Irving LB, Bowler SD, Kotsimbos T, Kelly PM (2013)

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN).

Communicable Diseases Intelligence; 37(3): E246-E252

Chiu C, McIntyre P (2013)

Pneumococcal vaccines – past, present and future.

Australian Prescriber; 36(3): 88-93

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D (2013)

High nasopharyngeal carriage of non-vaccine serotypes in Western Australian Aboriginal people following 10 years of pneumococcal conjugate vaccination.

PLOS ONE; 8: e82280

Retrieved 3 December 2013 from http://dx.doi.org/10.1371/journal.pone.0082280

de Kluyver R (2013)

Invasive pneumococcal disease surveillance Australia, 1 July to 30 September 2013.

Communicable Diseases Intelligence; 37(4): E448-E552

Deek H, Abbott P, Moore L, Davison J, Cameron S, DiGiacomo M, McGrath SJ, Dharmendra T, Davidson PM (2013)

Pneumococcus in Aboriginal and Torres Strait Islanders: the role of Aboriginal Health Workers and implications for nursing practice.

Contemporary Nurse; 46(1): 54-58

Gunaratnem PJ, Gilmour RE, Lowbridge C, McIntyre PB (2013)

Invasive pneumococcal disease.

New South Wales Public Health Bulletin; 24(3): 142-147

National Notifiable Diseases Surveillance System Annual Report Writing Group (2013)

Australia’s notifiable disease status, 2011: annual report of the National Notifiable Diseases Surveillance System.

Canberra: National Notifiable Diseases Surveillance System

Phung DT, Wang Z (2013)

Risk of pneumonia in relation to body mass index in Australian Aboriginal people.

Epidemiology and Infection; 141(12): 2497-2502

Smith-Vaughan HC, Binks MJ, Marsh RL, Kaestli M, Ward L, Hare KM, Pizzutto SJ, Thornton RB, Morris PS, Leach AJ (2013)

Dominance of haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation.

BMC Ear, Nose and Throat Disorders; 13: 12

Retrieved 8 October 2013 from http://dx.doi.org/10.1186/1472-6815-13-12

Western Australia Department of Health (2013)

Western Australian immunisation strategy 2013–2015.

Perth: Western Australia Department of Health

This strategy provides a vision for improving immunisation services in Western Australia (WA). The resource includes specific strategies to:

  • improve immunisation rates among children entering school as well as areas with low vaccination rates
  • improve immunisation rates among Aboriginal Australians
  • expand access to immunisation services by increasing capacity of health care providers
  • improve the immunisation consent process in WA
  • sustain mechanisms to ensure surveillance and follow-up of adverse events following immunisation
  • ensure stakeholder involvement in immunisation planning
  • meet performance benchmarks.

Abstract adapted from Western Australia Department of Health

2012

Australian Centre for Asthma Monitoring (2012)

Vaccination uptake among people with chronic respiratory disease.

Canberra: Australian Institute of Health and Welfare

Australian Indigenous HealthInfoNet (2012)

Summary of Australian Indigenous health, 2011.

Perth, WA: Australian Indigenous HealthInfoNet

Australian Institute of Health and Welfare (2012)

Australia's health 2012.

Canberra: Australian Institute of Health and Welfare

Barry C, Krause VL, Cook HM, Menzies RI (2012)

Invasive pneumococcal disease in Australia 2007 and 2008.

Communicable Diseases Intelligence; 36(2): E151-E165

Centre for Disease Control (2012)

NT notifications of diseases by onset date & districts: 1 January –31 December 2011 & 2010.

Darwin: Northern Territory Department of Health

Centre for Disease Control (2012)

Pneumovax 23 revaccination guidelines 2012.

Northern Territory Disease Control Bulletin; 19(1): 6-7

Coombs GW, Goering RV, Chua KYL, Monecke S, Howden BP, Stinear TP, Ehricht R, O'Brien FG, Christiansen KJ (2012)

The molecular epidemiology of the highly virulent ST93 Australian community staphylococcus aureus strain.

PLOS ONE; 7(8): e43037

Retrieved from http://dx.doi.org/10.1371/journal.pone.0043037

Fitzgerald T, Masseya PD, Islama F (2012)

Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction.

Western Pacific Surveillance and Response Journal; 3(2): 1-6

Guthrie JA, Lokuge KM, Levy MH (2012)

Influenza control can be achieved in a custodial setting: Pandemic (H1N1) 2009 and 2011 in an Australian prison.

Public Health; 126(12): 1032–1037

Hare KM, Binks MJ, Grimwood K, Chang AB, Leach AJ, Smith-Vaughan H (2012)

Culture and PCR detection of haemophilus influenzae and haemophilus haemolyticus in Australian Indigenous children with bronchiectasis.

Journal of Clinical Microbiology; Published ahead of print(http://jcm.asm.org/content/early/2012/04/26/JCM.00566-12.abstract):

Hare KM, Cheng AC, Smith-Vaughan H, Chang AC, Morris PS, Leach AJ (2012)

Concordance between nasopharyngeal cultures and pathogens in ear discharge and lower airway specimens from Indigenous children in the Northern Territory.

Paper presented at the OMOZ 2012. 2-4 May 2012, Fremantle, WA

Hare KM, Smith-Vaughan HC, Leach AJ (2012)

The bacteriology of lower respiratory infections in Papua New Guinean and Australian Indigenous children.

Papua New Guinea Medical Journal; 53(3/4): 151-165

Kyd J (2012)

Microbial infection and otitis media.

Paper presented at the OMOZ 2012. 2-4 May 2012, Fremantle, WA

New South Wales Centre for Epidemiology and Evidence (2012)

The health of Aboriginal people of NSW: report of the Chief Health Officer 2012.

Sydney: New South Wales Ministry of Health

New South Wales Ministry of Health Communicable Diseases Branch (2012)

Communicable diseases report, NSW, January and February 2012.

New South Wales Public Health Bulletin; 23(4): 94-98

Schaffer A, Muscatello D, Cretikos M, Gilmour R, Tobin S, Ward J (2012)

The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: a time series analysis.

BMC Public Health; 12: 869

Retrieved 12 October 2012 from http://dx.doi.org/10.1186/1471-2458-12-869

Sun W, Jacoby P, Riley TV, Bowman J, Leach AJ, Coates H, Weeks S, Cripps A, Lehmann D (2012)

Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia: a cohort study.

BMC Infectious Diseases; 12: 366

Retrieved 21 December 2012 from http://dx.doi.org/10.1186/1471-2334-12-366

Thomsen R, Smyth W, Gardner A, Ketchell J (2012)

Centrelink: an innovative urban intervention for improving adult Aboriginal and Torres Strait Islander access to vaccination.

Healthcare Infection; 17(4): 136-141

Thomson N, MacRae A, Brankovich J, Burns J, Catto M, Gray C, Levitan L, Maling C, Potter C, Ride K, Stumpers S, Urquhart B (2012)

Overview of Australian Indigenous health status, 2011.

Perth, WA: Australian Indigenous HealthInfoNet

2011

Flego KL, Truman G, Sheppeard V, Gilmour RE (2011)

Invasive pneumococcal disease in western Sydney, 2002–2010.

NSW Public Health Bulletin; 22(12): 219-221

Goggin LS, Carcione D, Mak DB, Dowse GK, Giele CM, Smith DW, Effler PV (2011)

Chronic disease and hospitalisation for pandemic (H1N1) 2009 influenza in Indigenous and non-Indigenous Western Australians.

Communicable Diseases Intelligence; 35(2): 172-176

Harvey RM, Stroeher UH, Ogunniyi AD, Smith-Vaughan HC, Leach AJ, Paton JC (2011)

A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence.

PLOS ONE; 6(5): e19650

Retrieved from http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0019650

Hull B, Dey A, Mahajan D, Menzies R, McIntyre PB (2011)

Immunisation coverage annual report, 2009.

Communicable Diseases Intelligence; 35(2): 132-148

Jacups SP, Cheng A (2011)

The epidemiology of community acquired bacteremic pneumonia, due to streptococcus pneumoniae, in the top end of the Northern Territory, Australia - over 22 years.

Vaccine; 29(33): 5386-5392

Massey PD, Kerry T, Osbourn M, Taylor K, Durrheim DN (2011)

Invasive pneumococcal disease in New South Wales, Australia: reporting Aboriginal and Torres Strait Islander status improves epidemiology: surveillance report.

Western Pacific Surveillance and Response Journal; 2(3): 1-4

Massey PD, Miller A, Saggers S, Durrheim DN, Speare R, Taylor K, Pearce G, Odo T, Broome J, Judd J, Kelly J, Blackley M, Clough A (2011)

Australian Aboriginal and Torres Strait Islander communities and the development of pandemic influenza containment strategies: community voices and community control.

Health Policy; 103(2-3): 184–190

Massey PD (2011)

Controlling communicable diseases in rural New South Wales: epidemiological research for directing health policy and practice.

Doctor of Public Health thesis, James Cook University: Townsville, Qld

Moore HC, Lehmann D, de Klerk N, Jacoby P, Richmond PC (2011)

Reduction in disparity for pneumonia hospitalisations between Australian indigenous and non-Indigenous children.

Journal of Epidemiology and Community Health; 66(6): 489-494

NNDSS Writing Group (2011)

Australia's notifiable diseases status, 2009: annual report of the National Notifiable Diseases Surveillance System.

Communicable Diseases Intelligence; 35(2): 61-131

Trauer JM, Laurie KL, McDonnell J, Kelso A, Markey PG (2011)

Differential effects of pandemic (H1N1) 2009 on remote and Indigenous groups, Northern Territory, Australia, 2009.

Emerging Infectious Diseases; 17(9): 1615-1623

Williams SR, Mernagh PJ, Lee MHT, Tan JT (2011)

Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine.

Medical Journal of Australia; 194(3): 116-120

 
Last updated: 17 October 2017
 
Return to top
spacing
general box

Contribute

Share your information » Give us feedback » Sign our guestbook »
spacing
spacing